$10.05
-0.17-1.66%
At close: -
$10.73
0.686.77%
After Hours: 9:07 AM EDT
Comments
Loading...
Rapport Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RAPP | Benzinga
Rapport Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS Estimate
$-0.700
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Rapport Therapeutics using advanced sorting and filters.
Rapport Therapeutics (RAPP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.57 | $-0.61 | 6.56 % |
| Q3 | 2024-11-07 | $-0.50 | $-0.57 | 12.3 % |
| Q2 | 2024-08-08 | $-1.70 | $-0.67 | -153.7 % |
Rapport Therapeutics (RAPP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Rapport Therapeutics (NASDAQ:RAPP) reporting earnings?
Rapport Therapeutics (RAPP) is scheduled to report earnings on May 10, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Rapport Therapeutics (NASDAQ:RAPP)?
The Actual EPS was $-0.57, which beat the estimate of $-0.61.
What were Rapport Therapeutics’s (NASDAQ:RAPP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.